These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15464074)

  • 1. Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats.
    Shimizu A; Miyoshi M; Sugie M; Ueyama J; Yamaguchi T; Sasaki T; Takagi K; Jin M; Miyamoto K; Tsuji A; Hasegawa T
    Eur J Pharmacol; 2004 Oct; 501(1-3):151-9. PubMed ID: 15464074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport.
    Yamaguchi S; Zhao YL; Nadai M; Yoshizumi H; Cen X; Torita S; Takagi K; Takagi K; Hasegawa T
    Antimicrob Agents Chemother; 2006 Jan; 50(1):80-7. PubMed ID: 16377671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion.
    Tahara H; Kusuhara H; Fuse E; Sugiyama Y
    Drug Metab Dispos; 2005 Jul; 33(7):963-8. PubMed ID: 15821041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein.
    Ji Y; Morris ME
    Biochem Pharmacol; 2005 Aug; 70(4):640-7. PubMed ID: 16002050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.
    Sugie M; Asakura E; Zhao YL; Torita S; Nadai M; Baba K; Kitaichi K; Takagi K; Takagi K; Hasegawa T
    Antimicrob Agents Chemother; 2004 Mar; 48(3):809-14. PubMed ID: 14982769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
    Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
    Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo.
    Speeg KV; Maldonado AL; Liaci J; Muirhead D
    J Pharmacol Exp Ther; 1992 Apr; 261(1):50-5. PubMed ID: 1348538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the pharmacokinetics and protein binding of enprofylline in Eisai hyperbilirubinemic rats.
    Nadai M; Hasegawa T; Wang L; Tagaya O; Nabeshima T
    Drug Metab Dispos; 1994; 22(4):561-5. PubMed ID: 7956730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.
    Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Aug; 310(2):648-55. PubMed ID: 15131241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats.
    Asakura E; Nakayama H; Sugie M; Zhao YL; Nadai M; Kitaichi K; Shimizu A; Miyoshi M; Takagi K; Takagi K; Hasegawa T
    Eur J Pharmacol; 2004 Jan; 484(2-3):333-9. PubMed ID: 14744620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney.
    Hori R; Okamura N; Aiba T; Tanigawara Y
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats.
    Kiso S; Cai SH; Kitaichi K; Furui N; Takagi K; Takagi K; Nabeshima T; Hasegawa T
    Anticancer Res; 2000; 20(5A):2827-34. PubMed ID: 11062690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein function and expression during obstructive cholestasis in rats.
    Micuda S; Brcakova E; Fuksa L; Cermanova J; Osterreicher J; Hroch M; Mokry J; Pejchal J; Martinkova J; Staud F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):404-12. PubMed ID: 18403942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution.
    Burgio DE; Gosland MP; McNamara aPJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):911-7. PubMed ID: 9864272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
    Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
    Abe F; Ueyama J; Kimata A; Kato M; Hayashi T; Nadai M; Saito H; Takeyama N; Noguchi H; Hasegawa T
    Life Sci; 2008 Aug; 83(7-8):229-35. PubMed ID: 18638490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
    Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
    Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
    Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
    Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of intestinal drug transporters in chronic renal failure in rats.
    Naud J; Michaud J; Boisvert C; Desbiens K; Leblond FA; Mitchell A; Jones C; Bonnardeaux A; Pichette V
    J Pharmacol Exp Ther; 2007 Mar; 320(3):978-85. PubMed ID: 17135344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
    Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.